This Is MS | Unbiased Multiple Sclerosis Research, News, and Community

Modules

· Home
· Content
· Downloads
· Encyclopedia
· FAQ
· Feedback
· Forums
· Journal
· Private Messages
· Recommend Us
· Search
· Site_Map
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links
· Your Account

Google

These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS.

Languages

Select Interface Language:

Who's Online

There are currently, 200 guest(s) and 16 member(s) that are online.

You are Anonymous user. You can register for free by clicking here

Next Step

From the creators of This is MS comes Experience Project

EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at Experience Project.

Get started by sharing your Multiple Sclerosis story.

Donations

To remain unbiased, This is MS does not accept corporate sponsorships.

Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you!

Stories Archive

This Is MS: All Stories

Articles	comments	reads	Score	Date	Actions
Research: Oral Therapy Laquinimod to Start Phase III Trials for RRMS	3	4606	2	2007-06-07
MS Walking Improvement Drug Gets FDA Help	3	3498	5	2007-05-23
Daclizumab Shows Promise in Phase II Trial for Relapsing Remitting MS	4	2790	0	2007-03-19
Minimal Changes in Cognitive Function of Relapsing-Remitting MS'ers in a 10-year	4	3235	3.6	2007-03-06
PML Seen with Rituxan for Lupus	4	3800	4.53	2006-12-20
News: Vitamin D Reduces Risk of Multiple Sclerosis	4	3663	3.71	2006-12-20
Opexa Begins Phase IIb Study on Tovaxin	4	3783	4.78	2006-09-20
News: Oral Therapy FTY720 (Fingolimod) Shows Promise for MS	4	7022	4.62	2006-09-16
Rituxan Has Positive Phase II Results	4	5694	3.9	2006-08-28
Teva to Examine Neutralizing Antibodies to Interferon	4	3305	4.83	2006-08-21
Research: Fathers More Likely to Pass MS to Children	4	2889	3.28	2006-07-27
And Then There Were Six (Again)	4	3640	3	2006-07-24
MS and Diabetes Linked	4	3329	3.28	2006-07-13
News: Tysabri Approved For Return in Europe	4	2230	4	2006-06-29
Tysabri Price Rises Nearly Twenty Percent	4	4537	3.33	2006-06-09
News: Tysabri Cleared to Return to Market	4	2699	4.57	2006-06-05
Hope and Heartbreak: The Path of Tysabri as a Treatment for Multiple Sclerosis	4	2873	4.66	2006-06-05
Biogen Buys Another Promising MS Drug (BG-12)	4	4565	3	2006-06-01
Early Treatment Favoured for MS	4	2454	4	2006-05-26
Elan Says Tysabri on Track, Considers Price Hike	4	2830	4	2006-05-25
Research: Monthly IV Steroids Could Prevent Relapses	4	3121	4.2	2006-05-25
Possible Method of Action for Copaxone Discovered	4	4167	4.3	2006-05-23
Research: Keppra (Levetiracetam) shows Promise Against Tremor	4	3033	4.33	2006-05-22
First Formal Low Dose Naltrexone Study Results to be Presented	4	4535	3.83	2006-05-19
Possible Shift in Thinking about how Multiple Sclerosis Develops	4	3685	4.5	2006-05-17
BioMS expands MBP8298 trial to RRMS patients	4	2623	4.33	2006-05-16
Research: Daclizumab Method of Action Surprises Researchers	4	4124	4.91	2006-03-30
News: FDA Extends Tysabri Review by up to 90 Days	4	1980	1.8	2006-03-22
US FDA PANEL UNANIMOUS: TYSABRI SHOULD RETURN	4	2229	5	2006-03-08
News: First Day of Tysabri AC Meeting Over	4	1691	5	2006-03-07
News: In Progress: Tysabri FDA Advisory Panel Review Meeting	4	1636	3.33	2006-03-07
News: New Tysabri Results Published in New England Journal of Medicine	4	2314	4	2006-03-01
Research: Interesting new Research Abstracts on Tsyabri (Natalizumab)	4	5835	3.66	2006-02-28
News: Tysabri Cleared for Clinical Trial Use	4	2000	4.71	2006-02-15
Clinical Trials: MN-166 Enters Phase II trials in US	4	2322	4	2006-02-06
Tysabri to Receive FDA Verdict by end of March	4	2749	3	2006-01-24
News: FDA grants Priority Review to Tysabri Supplemental Application	4	2342	3.42	2005-11-18
Research: Component of Turkey (Tryptophan) Promising in MS	4	4904	3.42	2005-11-07
News: Tysabri Crohn's and RA Safety Review Complete; No New PML	4	3737	1.8	2005-10-17
Research: Novartis Oral Therapy FTY-720 Shows Phase II Success	4	6259	4.71	2005-10-03
News: Tysabri Supplemental Application Submitted to FDA	4	3383	4	2005-09-26
News: Elan and Biogen Plan Re-Launch of Tysabri	4	3056	3.2	2005-09-20
Research: Stem Cells Repair Cord Damage; Produce Myelin	4	4690	4.5	2005-09-20
News: Campath Trials Temporarily Halted; Shows Promise	4	2733	2.75	2005-09-20
Research: Long-Term Antibiotic Use Raises Cold and Flu Risk	4	3441	0	2005-09-20
Research: Oral Contraceptives (Estrogen) Cut MS Risk	4	2480	4.5	2005-09-20
Research: Study on Chlamydia Pneumonia Infection in Multiple Sclerosis Patients	4	4323	3.5	2005-09-12
Research: Familial Risk of Multiple Sclerosis	4	2258	3.25	2005-08-29
Research: Alpha-4 Integrin Inhibitors (e.g., Tysabri) May Sponsor Remyelination	4	3929	5	2005-08-23
Research: Vitamin D shows Promise in Treating RRMS	4	2724	1	2005-08-23
Research: Birth Order has no Effect on MS Risk	4	1516	4	2005-08-22
Tysabri MS Patients Screened: No new PML cases	4	2070	4	2005-08-10
News: Biogen Purchases Rights to Daclizumab From PDL	4	2555	0	2005-08-03
Lessons from Campath: Early Protection of CNS Critical	4	2256	4.5	2005-07-29
Biogen Provides Update on Status of Tysabri	4	1824	4.5	2005-07-27
Research: Minocycline Downregulates T-Cell Activity	4	2947	4.66	2005-07-24
PRISMS Crossover Study Corroborates Benefit of Rebif as Treatment for RRMS	4	1368	0	2005-07-23
News: Biogen, Elan sued over Tysabri PML Death	4	2228	4	2005-07-22
Research: Restless Leg Syndrome More Common in MS'ers	4	2778	4	2005-07-22
Stem cells may automatically protect brain	4	1732	5	2005-07-14
News: Aimspro Update -- It is still Alive	4	3037	4.14	2005-07-07
Theory: Tysabri PML link may be due to Overdosing	4	1537	5	2005-07-06
Emotional Incontinence Drug Submitted for Final Approval	4	2332	1	2005-07-02
Tysabri Posts Positive Crohn's Data; Safety Review ''on-track''	4	2003	4.35	2005-07-01
Rumors of a 5th Tysabri PML Case... And Thoughts on the "Cases" yet to Come	4	1199	0	2005-06-14
Doubt Cast on 4th PML Case	4	1116	0	2005-06-10
New England Journal of Medicine Reviews Tysabri PML Cases	4	2330	2.33	2005-06-09
FDA-Approved Drugs: Complete FDA Biologics Application for Tysabri	4	1463	0	2005-06-05
More Details on the Suspected 4th Tysabri PML Case	4	1725	3.66	2005-06-03
Reports of a 4th Tysabri-PML Case	4	1397	5	2005-06-02
Tysabri: Not IF but WHEN	4	1706	4.75	2005-05-26
New Article: The JC Virus Story in MS (PML-Tysabri related)	4	2058	5	2005-05-25
Research: Biogen Discovers Myelin-Production Protein	4	4247	3.33	2005-05-17
Research: A Case of Recovery from PML	4	1414	4	2005-05-15
Research: Viagra (sildenafil citrate) Useful for Men with MS	4	1450	0	2005-05-14
Research: Supplement N-acetyl-L-cysteine (NAC) shown beneficial in EAE	4	2260	4.33	2005-05-14
News: Acorda Gets FDA Assistance for Phase III Trial of Fampridine-SR	4	2664	4.5	2005-05-04
Research: Possible Mode of Action for Statins in MS	4	1926	5	2005-04-29
Editorials: Possible Tysabri Comeback Scenario	4	891	4	2005-04-28
Tysabri Safety Review to be Completed by Late Summer	4	951	3	2005-04-27
Provigil Ineffective for MS Fatigue; Aspirin Might Help	4	3684	3	2005-04-23
Contacting the FDA About Tysabri	4	1410	5	2005-04-20
News: Sativex (Marijuana Spray for MS) Approved in Canada	4	2245	4.83	2005-04-20
Tysabri 2 Year Results Out: Strong Efficacy and Reduction of Disease Progression	4	2479	5	2005-04-12
Daval Explains why Aimspro Trial Halted	4	1974	4.2	2005-04-01
Revealing Medical History of 3rd Tysabri Patient with PML	4	13915	4.81	2005-03-31
3rd Case of PML found for Tysabri	4	1362	4.75	2005-03-30
Laquinimod (oral therapy) Successful in Phase II Trial	4	3156	5	2005-03-23
News: Aimspro Successful in Optic Neuritis Trials	4	7895	4.6	2005-03-21
Research: Smoking Raises Risk of MS Conversion to Secondary Progressive	4	1820	5	2005-03-19
News: FDA: Avonex can cause Severe Liver Injury	4	2161	4	2005-03-16
News: More Fallout: Glaxo Halts MS Drug Trial on Tysabri Recall	4	1336	4	2005-03-16
News: US Army to take Brain Injury Drug to Trials	4	1350	5	2005-03-16
News: Antisense Halts Phase II Trial for Tysabri-like ATL1102	4	2007	5	2005-03-11
News: 2nd Patient on Tysabri/Avonex Combo Confirmed with PML	4	1604	0	2005-03-04
Daval Halts Aimspro Trial over ''Hospital Protocol Concerns''	4	2110	4.2	2005-03-04
News: New Phase II NeuroVax Study for MS	4	4943	4.72	2005-03-01
News: Tysabri could be ''back on the market by Fall''	4	3267	4.68	2005-02-28
Tysabri Voluntarily Suspended	4	1914	5	2005-02-28
News: New Study: Combination of Copaxone and Anti-Oxidant NAC	4	3059	3.66	2005-02-22
News: Tysabri 2 year Data Out: Significant Reduction in Disability and Relapses	4	3690	4	2005-02-17
News: Elan's Investor Conference Call Notes Regarding Tysabri	4	1241	0	2005-02-08
Research: Statins Beneficial for Spinal Cord Injury (in rats)	4	1671	3	2005-02-07
News: Link to Biogen Investor Call February 7th, 2005	4	1022	0	2005-02-07
Tysabri Online Educational Seminar by the Cleveland Clinic	4	1782	0	2005-01-25
News: Novartis' Oral MS Therapy FTY720 Successful in Phase II Trials	4	8156	3.5	2005-01-20
Research: Sex Hormones Modulate Brain Injury in Multiple Sclerosis	4	2793	5	2005-01-16
Treatments: Tysabri Mode of Action Video	4	2287	4	2005-01-16
Rumors: Tysabri a Hit at Major Healthcare Conference	4	1499	4	2005-01-15
Rumors: Let the wars begin: Rebif versus Tysabri	4	1666	5	2005-01-14
Research: Study Shows Weight Training Gives MS Patients Physical, Emotional Benefits	4	3301	4.5	2005-01-13
News: Phase III Trial of Oral MS Therapy Mylinax (Cladribine) Initiated	4	4571	5	2005-01-12
National Multiple Sclerosis Society's 2004 MS Summary	4	2282	4.5	2004-12-08
News: Tysabri Product Information	4	3096	5	2004-11-28
Reactions to Tysabri Approval (also known as Antegren or Natalizumab)	4	3334	4.41	2004-11-25
News: Antegren (Tysabri) Receives FDA approval for Treatment of Relapsing Remitting MS	4	3905	3.88	2004-11-23
Tysabri!?! Antegren to be renamed...	4	1284	0	2004-11-23
News: GlaxoSmithKline Updates on new Oral MS Therapy 683699	4	4851	4	2004-11-23
Research: Alzheimer's Drug Aricept Helps Memory in Multiple Sclerosis	4	2011	0	2004-11-15
Antegren One-Year Data Out: 66% Reduction in Relapses	4	3718	3.66	2004-11-08
Non-Antibacterial Tetracylines Protective in Animal MS Models	4	2956	4.28	2004-10-27
News: Rebif Market Share Growing; Antegren Viewed as Biggest Threat	4	2526	0	2004-10-26
Research: Coffee Linked to Inflammation	4	3438	0	2004-10-19
Research: IV Immunoglobulin After First MS Event Is A Preventative	4	2048	3.5	2004-10-12
Research: After 10 years, 91% of Copaxone Users Still Walk Unaided	4	2943	4	2004-10-11
Research: MS Patients More Sensitive to Gluten	4	3252	4.57	2004-10-08
Teaching MS Patients to Save Energy Curbs Fatigue	4	1830	4	2004-10-08
Research: Long Term Study of Rebif Shows Positive Results	4	1762	3.66	2004-10-08
Research: Component of a Virus (Synctin) Linked to Multiple Sclerosis	4	4166	4.90	2004-09-28
Research: Bacterial Infection Linked to Crohn's Disease (Is Bacteria the Cause of MS?)	4	2836	4	2004-09-17
Research: Research Theorizes why Myelin Breakdown Occurs in MS	4	1793	5	2004-09-15
News: Talk with Teva and Active Biotech about Laquinimod (Oral Therapy for MS)	4	2410	4	2004-09-15
Research: Hepatitis B Vaccine Linked with Higher Incidence of Multiple Sclerosis	4	1906	5	2004-09-14
News: Researcher: Stem Cell Treatment for MS ''likely soon''	4	2939	4.2	2004-09-08
Carbon Monoxide Poisoning Induces Similar Changes to Myelin as seen in MS	4	1885	4.5	2004-09-08
Research: MS'ers with Few Symptoms Over Time Likely to Stay Well; Do Not Require Treatment	4	3552	4.61	2004-08-31
Research: Pregnancy best treatment for MS; Estrogen is key	4	4569	4.33	2004-08-27
News: Stem Cells Eliminate Rheumatoid Arthritis in Patient	4	1652	0	2004-08-27
Excessive Emotions Drug Neurodex Successful in Phase III Trial	4	1655	0	2004-08-25
Research: Ibuprofen Best for Treating Post-Avonex-Injection Side Effects	4	1950	2.5	2004-08-20
Research: Chiropractic Correction of Neck Injuries may Halt MS Progression	4	4546	4.07	2004-08-20